Entretal focuses exclusively on healthcare and life sciences — the sectors where market expansion is most complex, most regulated, and most consequential.
Entretal's sector focus is not a limitation — it's a competitive advantage. By concentrating exclusively on HealthTech, MedTech, and life sciences, we've built the depth of knowledge, the regulatory understanding, and the stakeholder networks that generalist advisors simply can't match.
Software platforms, AI diagnostics, remote monitoring, and digital therapeutics navigating complex regulatory and reimbursement landscapes in both the US and GCC/MENA.
Examples
Hardware and device companies managing regulatory clearance, clinical evidence generation, and procurement access across multiple jurisdictions.
Examples
Life sciences companies seeking market access, distribution partnerships, and commercial infrastructure in new geographies across the GCC and emerging markets.
Examples
Service providers and infrastructure companies building or expanding clinical operations, hospital networks, and care delivery models across the GCC and MENA region.
Examples
The US and GCC/MENA represent two of the world's most dynamic healthcare markets — one defined by innovation and capital, the other by rapid infrastructure investment and unmet clinical need. The opportunity to move technology, capital, and expertise between them is significant. The barriers to doing so successfully are equally significant. Entretal exists to bridge that gap.